News

NKF Recognized Regional Renal Dietitian – Region 4: Nadiya Lakhani, RDN, CSR, LD

By

Congratulations to Nadiya Lakhani, RDN, CSR, LD for receiving the Council on Renal Nutrition (CRN) Recognized Regional Renal Dietitian Award for Region 4 during the National Kidney Foundation 2016 Spring Clinical Meeting which was recently held at the Hynes Convention Center in Boston, Massachusetts from April 27-May 1.  The Regional Recognized Renal Dietitian of the Year … Continued

OPTN/UNOS Patient Affairs Committee Appoints Mary Beth Callahan as Regional 4 Representative

By

Congratulations to Mary Beth Callahan, ACSW, LCSW on her appointment as the Regional 4 representative to the OPTN/UNOS Patient Affairs Committee.  OPTN/UNOS committees work together to achieve key strategic plan goals and make crucial decisions that help shape organ donation and transplantation policy. The Organ Procurement and Transplantation Network (OPTN) is operated under contract with … Continued

DNA Presents to Local Medical Community

By

Several Dallas Nephrology Associates (DNA) physicians recently presented at the National Kidney Foundation (NKF) primary care physician education program, CKDinform:  Early Detection and Prevention, on April 2, 2016 at the Omni Hotel in Las Colinas, TX.  The symposium was well attended by members of the local medical community. CKDinform is an accredited CME program with … Continued

2016 NKF Presentation

By

Sandra M. Lauriat, MD, FACP and Freda L. Levy, MD, FACP of Dallas Nephrology Associates recently presented “Everyday Heroes Living with Kidney Disease” at the National Kidney Foundation’s Patient & Communication Education Seminar & Luncheon. The event was held at the Doubletree Hotel Dallas in Dallas, TX on March 13, 2016 and was attended by … Continued

A Case of MPGN Caused by MGRS

By

By Nilson Feliz, MD, Manuel Fernandez, MD, Lisa M. Sebastian, MD, Roberto L. Collazo-Maldonado, MD, FACP A 60-year old African American man was referred for evaluation of nephrotic syndrome. His past medical history was positive for HTN, DM, and Hepatitis C — successfully treated with ombitasvir/periteprevir/dasabuvir for three months. His hepatitis C viral load was … Continued

Screening for Chronic Kidney Disease

By

By Harold Szerlip, MD MS(ED), FACP, FCCP, FASN, FNKF, CCRP and Bernard V. Fischbach, MD, CCRP Chronic kidney disease (CKD) is a general term for diverse disorders affecting kidney structure and function with a variable clinical presentation. The Centers for Disease Control (CDC) estimates that more than 37 million adults, in the U.S., may have … Continued

Blood Pressure Management in the Post-SPRINT: The Race Is On

By

By Harold Szerlip, MD MS(ED), FACP, FCCP, FASN, FNKF, CCRP Get ready for a significant change in the hypertension guideline. The SPRINT trial, which compared intensive treatment for hypertension (< 120 mm Hg systolic) to the present guidelines (< 140 mm Hg) was terminated early by the data safety monitoring committee because of a > … Continued

RDRI Begins First Clinical Trial

By

The Renal Disease Research Institute (RDRI) is a new research entity affiliated with Dallas Nephrology Associates. There is significant ethical oversight of this entity through RDRI’s Board of Managers and Scientific Review Committee. Currently, there are several potential clinical research trials in the pipeline. RDRI’s first active clinical trial is a device trial spearheaded by … Continued

Dr. Hull Receives 2016 Simmons Legacy Award

By

Dr. Alan R. Hull, former President of Dallas Nephrology Associates, Receives Prestigious Award Congratulations to Dr. Alan R. Hull upon his receipt of the prestigious 2016 Harold and Annette Simmons Legacy Award.  The award is presented each year to a key philanthropic individual or family who is committed to the well-being of the North Texas … Continued

Dr. Kim Rice Addresses Outcomes in Kidney Transplantation in The New England Journal of Medicine

By

Dr. Kim M. Rice recently co-authored, Belatacept and Long-Term Outcomes in Kidney Transplantation, in The New England Journal of Medicine which concluded that seven years after transplantation, patient and graft survival and the mean eGFR were significantly higher with belatacept than with cyclosporine. Dr. Rice joined Dallas Nephrology Associates in 1998 and is board certified … Continued